口服谷氨酰胺颗粒对烧创伤患者的疗效及安全性分析

Analysis of the therapeutic effect and the safety of glutamine granules per os in patients with severe burns and trauma

目的 观察口服谷氨酰胺 (Gln)颗粒对烧 (创 )伤及大手术患者的疗效及可能发生的不良反应。 方法 采用随机双盲、安慰剂对照法 ,将受试患者分为Gln组和对照组 ,每组 6 0例 ,两组患者采用等氮、等热量的营养支持。Gln组口服或管饲Gln 0.5g·kg-1·d-1,对照组使用同等剂量的安慰剂甘氨酸 ,疗程均为 7d。比较用药前后两组患者肠黏膜屏障功能、蛋白代谢、免疫功能、肝和肾功能的变化及不良反应等。 结果 伤后两组患者血浆Gln浓度明显低于正常值 ,而血浆二胺氧化酶(DAO)活性、内毒素含量、肠黏膜通透性 [尿乳果糖 /甘露醇 (L/M)]及尿氮排量均明显增高 ;但Gln组用药 7d后血浆Gln浓度与用药前比较增加 38.0 4 % (P <0.0 1)。Gln组血浆前白蛋白、转铁蛋白及白细胞介素 2 (IL 2)含量均显著高于对照组 (P <0.0 1),升幅分别为 2 1.19%、5 1.11%、5 7.5 4 %。血浆DAO活性、L/M比值、内毒素含量及尿氮排量明显低于对照组 ,降幅分别为 4 7.2 6 %、5 2 .18%、2 2 .2 2 %、2 7.78% (P <0.0 5或 0 .0 1)。两组患者的血浆总蛋白、白蛋白、血尿常规及肝、肾功能在用药前后变化不明显 (P >0.0 5)。用药后有少数患者出现轻微不良反应如恶心、腹泻和便秘等 ,2～ 3d后自行缓解 ,两组间比较 ,差异无显著性意义 (P >0.0 5)。?

Objective To observe the therapeutic effect and possible side effects of glutamine granules per os in patients with trauma, burns and major operations. Methods Patients inflicted with severe burns, trauma and major operations were enrolled in the study. One hundred and twenty patients were randomly divided into two groups, 60 in control group (C) and 60 in glutamine group (Gln). Randomized double blind and placebo control methods were employed in the study. All the patients in both groups were given diet with equal calories and equal nitrogen content. The patients in Gln group received glutamine granules in dose of 0.5 g·kg -1 ·d -1 orally or by gavage, while those in C group received same dose of placebo (glycin) for 7 days. The changes in the intestinal mucosal barrier function, the protein metabolism, the immune function, hepatic and renal functions, and the incidence of side effects of the medication in both groups of patients were observed and compared before and after the supplementation of glutamine or glycin. Results The plasma contents of glutamine, proteins and interleukin 2 in both groups were all lower than normal values. But the plasma diamine oxidase (DAO) activity, endotoxin content, intestinal mucosal permeability (urine lactose/mannitol, L/M) and urine excretion of nitrogen increased obviously in both groups. The plasma glutamine concentration in Gln group increased by 38.04% after the administration of Gln for 7 days (P<0.01). The plasma contents of pro albumin, transferrin, and IL 2 were obviously higher than those in the C group (the increase rates were 21.19%, 51.11%, 57.54%, respectively, P<0 01). The plasma DAO activity, L/M ratio, endotoxin content and urine nitrogen excretion in Gln group were evidently lower than those in C group( the decrease rates were 47.26%, 52.18, 22.22% and 27 78%, respectively, P<0.05 or 0.01).There was no obvious difference in the plasma levels of total protein and albumin, the indices in blood and urine test,or the hepatic and renal functions between the two groups before and after the amino acid supplementation. Mild side effects such as nausea, diarrhea, constipation occurred in both groups, but all of them disappeared spontaneously afterwards (P>0.05). Conclusion Oral administration of glutamine could be helpful to increase plasma concentration of glutamine and to ameliorate obviously the intestinal mucosal injury, to promote systemic protein synthesis and to inhibit protein catabolism and to upgrade systemic immune function with little side effect in patients with severe injury.